COVID-19 and acute mesenteric ischemia: A review of literature

Singh, Balraj; Kaur, Parminder

doi:10.1016/j.htct.2020.10.959

Cited by 40 publications

(55 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Further to this, in order to reduce morbidity and mortality patients require fluid resuscitation, restoration of flow in the mesenteric arterial / venous tree with or without bowel resection, and inotropic support. [ 14 , 15 ]…”

Section: Discussionmentioning

confidence: 99%

Our early experience with mesenteric ischemia in COVID-19 positive patients

Mahruqi

Stephen

Abdelhedy

et al. 2021

Annals of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Our early experience with mesenteric ischemia in COVID-19 positive patients

Mahruqi

Stephen

Abdelhedy

et al. 2021

Annals of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Treatment of this life-threatening condition includes surgical resection of the necrotic bowel, restoration of blood flow to the ischemic intestine and supportive measure - gastrointestinal decompression, fluid resuscitation, hemodynamic support [ 9 ]. Endovascular management of AMI is preferred over the standard surgical approach due to a reduced mortality and morbidity rates [ 10 ].…”

Section: Discussionmentioning

confidence: 99%

Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report

Dinoto¹,

Ferlito²,

Marca³

et al. 2021

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

Introduction COVID-19 is an infectious disease that has been associated not only with respiratory complications. The COVID-19 disease includes, also damage to other organ systems as well as coagulopathy. The present report describes a case of COVID-19 presenting with acute mesenteric ischemia (AMI) and subsequent acute limb ischemia (ALI). Presentation of case An 84-years old hospitalized female patient presenting diabetes and recent COVID-19 reported acute onset of abdominal pain and typical findings of AMI. The CT-angiography confirmed the AMI secondary to a superior mesenteric artery (SMA) occlusion. The patient was managed through an endovascular approach using a SMA mechanical thrombectomy and stenting with a good result. Discussion Treatment of this life-threatening condition includes surgical resection of the necrotic bowel, restoration of blood flow to the ischemic intestine and supportive measure - gastrointestinal decompression, fluid resuscitation, hemodynamic support. Endovascular management of AMI is preferred over the standard surgical approach due to a reduced mortality and morbidity rates. Imaging findings of intestinal necrosis, however, represent an indication for AMI surgical treatment with explorative laparotomy. Different endovascular solutions have been employed to address AMI including mechanical thrombectomy, local thrombolysis, and PTA-stenting. Conclusion COVID-19 clinical presentation can be atypical, including gastrointestinal symptoms. If a first embolic event occurs, an aggressive anticoagulation treatment could be inefficient to reduce the risk of subsequent embolization events. The limited life expectancy of such revascularization procedures should orientate towards less invasive treatments.

show abstract

“…The goal of treatment is to restore intestinal blood flow as promptly as possible after initial management with systemic anticoagulation and empiric broad-spectrum antibiotics [ 11 ]. Surgical resection of necrotic bowel, supportive measures including gastrointestinal decompression, fluid resuscitation, and hemodynamic support are the backbone of AMI therapy [ 12 ]. Survival is approximately 50% when the diagnosis is made within one day but drops to less than 30% with delayed diagnosis [ 13 ].…”

Section: Discussionmentioning

confidence: 99%

A Rare Case of Acute Mesenteric Ischemia in the Setting of COVID-19 Infection

Krothapalli¹,

Jacob²

2021

Cureus

View full text Add to dashboard Cite

Severe respiratory syndrome coronavirus 2 (SARS-CoV-2) is well known for causing respiratory and other extrapulmonary manifestations. Patients infected with coronavirus disease 2019 (COVID-19) may demonstrate atypical presentations with gastrointestinal symptoms. Clinicians managing these patients should reserve a high index of suspicion for the rare complication of acute mesenteric ischemia (AMI). It is a challenging diagnosis that is often missed when presenting symptoms are subtle and nonspecific like nausea, emesis, or diarrhea. Outcomes are typically catastrophic and fatal as bowel ischemia progresses to necrosis but may be averted with timely diagnostic and therapeutic methods to swiftly restore blood flow.

show abstract

COVID-19 and acute mesenteric ischemia: A review of literature

Cited by 40 publications

References 14 publications

Our early experience with mesenteric ischemia in COVID-19 positive patients

Our early experience with mesenteric ischemia in COVID-19 positive patients

Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report

A Rare Case of Acute Mesenteric Ischemia in the Setting of COVID-19 Infection

Contact Info

Product

Resources

About